𝔖 Bobbio Scriptorium

✦ LIBER ✦

Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?

✍ Scribed by Mollee, P; Lazarus, H M; Lipton, J

Book ID: 110013726
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 140 KB
Volume: 31
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1704040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

816 Development of an active CHOP-modifi

816 Development of an active CHOP-modified regimen which allows more continuous and better tolerated treatment for diffuse aggressive non-hodgkin's lymphomas (NHL)

✍ G. Martinetti; E. Zucca; M. Aapro; E. Cavalli 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 143 KB

A Randomized Phase III Study of Gemcitab

A Randomized Phase III Study of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin as Salvage Chemotherapy Followed by Posttransplantation Rituximab Maintenance Therapy Versus Observation for Treatment of Aggressive B-Cell and T-Cell Non-Hodgkin's Lymphoma

✍ Crump, Michael; Shepherd, Lois; Lin, Boris 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB